Evotec Se Adr stock is traded at $1.69, with a volume of 84,927. It is down -2.87% in the last 24 hours and up +10.46% over the past month. Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Previous Close:
$1.74
Open:
$1.71
24h Volume:
84,927
Relative Volume:
0.93
Market Cap:
$600.61M
Revenue:
$863.66M
Net Income/Loss:
-$225.27M
P/E Ratio:
-
EPS:
-$0.6342
Net Cash Flow:
-$63.28M
1W Performance:
+9.03%
1M Performance:
+10.46%
6M Performance:
-44.95%
1Y Performance:
-43.48%
1-Day Range:
$1.66$1.71
1-Week Range:
$1.53$1.82
52-Week Range:
$1.33$3.87
Evotec Se Adr Stock (EVO) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS